Importance of Ki-67 Labeling in Oral Leukoplakia with Features of Dysplasia and Carcinomatous Transformation: An Observational Study over 4 Years

Abstract

Background Early detection of dysplastic changes within oral potentially malignant disorders is the mainstay to prevent oral cancer. Ki-67 is one of the most useful antigens in this purpose.

Aims The study aims were to recognize and mutually compare the proliferative status of idiopathic oral leukoplakia (OL) patches, which presented through different forms of dysplasia and carcinoma.

Settings and Design In 4 years of observation, cumulatively 140 OL lesions were included for examination. The wholesome Ki-67 labeling scores in each of the subgroups were calculated.

Subjects and Methods The World Health Organization recommended histopathological classification was used to categorize the dysplastic and malignant lesions. Paraffin-embedded tissue sections were processed for Ki-67 immunostaining. The labeling indices (LIs) were quantified semiquantitatively at the site of maximal reactive cells on tissue sections.

Statistical Analysis The statistical comparison was performed by means of the SPSS software (Version 16.0 SPSS Inc.). A p-value < 0.05 was considered as the benchmark for statistical significance.

Results A steady and significant increment in Ki-67 expression was discovered from dysplastic to malignant OL patches compared with normal mucosa. The labeling differences were significant between normal mucosa and mild dysplasia, as well as between mild, moderate, and severe dysplasia. However, the expression did not differ significantly with the severity of oral cancers.

Conclusions Ki-67 is a useful molecular marker of carcinogenesis in OL. It also serves worthwhile in separating marginally dysplastic lesions, such as mild dysplasia or verrucous carcinoma from their benign epigones.

Keywords

immunohistochemistry - Ki-67 - oral epithelial dysplasia - oral leukoplakia - squamous cell carcinoma

Publikationsverlauf

Artikel online veröffentlicht:
14. Dezember 2020

• References

• 1 Sridharan G. Epidemiology, control and prevention of tobacco induced oral mucosal lesions in India. Indian J Cancer 2014; 51 (01) 80-85
• 2 Takiar R, Krishnan SK, Shah VP. A model approach to calculate cancer prevalence from 5 years survival data for selected cancer sites in India–part II. Asian Pac J Cancer Prev 2014; 15 (14) 5681-5684
• 3 Dwivedi N, Chandra S, Kashyap B, Raj V, Agarwal A. Suprabasal expression of Ki-67 as a marker for the severity of oral epithelial dysplasia and oral squamous cell carcinoma. Contemp Clin Dent 2013; 4 (01) 7-12
• 4 Birajdar SS, Radhika M, Paremala K, Sudhakara M, Soumya M, Gadivan M. Expression of Ki-67 in normal oral epithelium, leukoplakic oral epithelium and oral squamous cell carcinoma. J Oral Maxillofac Pathol 2014; 18 (02) 169-176
• 5 Reddy VM, Saxena S. Assessment of Ki-67 in healthy, premalignant, and malignant lesions of oral mucosa and its predictive role in disease progression. Int J Oral Med Sci 2010; 9: 67-74
• 6 Kumar P, Kane S, Rathod GP. Coexpression of p53 and Ki 67 and lack of c-erbB2 expression in oral leukoplakias in India. Braz Oral Res 2012; 26 (03) 228-234
• 7 Sinanoglu A, Soluk-Tekkesin M, Olgac V. Cyclooxygenase-2 and Ki67 expression in oral leukoplakia: a clinicopathological study. J Oral Maxillofac Res 2015; 6 (02) e3
• 8 Kannan S, Chandran GJ, Pillai KR. et al. Expression of p53 in leukoplakia and squamous cell carcinoma of the oral mucosa: correlation with expression of Ki67. Clin Mol Pathol 1996; 49 (03) M170-M175
• 9 Humayun S, Prasad VR. Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: an immunohistochemical study. Natl J Maxillofac Surg 2011; 2 (01) 38-46
• 10 Barnes L, Eveson JW, Reichart P, Sidransky D. eds. WHO Classification of Tumours. Pathology & Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005
• 11 Salati NA. Diagnostic potential of epithelial biomarkers in oral diseases-lmmunohistochemical basis. IOSR J Dent Med Sci 2013; 5: 37-40
• 12 Raju B, Mehrotra R, Oijordsbakken G, Al-Sharabi AK, Vasstrand EN, Ibrahim SO. Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters. Anticancer Res 2005; 25 (6C) 4699-4706
• 13 Nasser W, Flechtenmacher C, Holzinger D, Hofele C, Bosch FX. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias. J Oral Pathol Med 2011; 40 (08) 629-635
• 14 Yagyuu T, Obayashi C, Ueyama Y. et al. Multivariate analyses of Ki-67, cytokeratin 13 and cytokeratin 17 in diagnosis and prognosis of oral precancerous lesions. J Oral Pathol Med 2015; 44 (07) 523-531
• 15 Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 2008; 37 (03) 127-133
• 16 Kumar KV, Chaithanya KH, Punde P, Thorat A, Jangam AG, Deepthi S. Comparative evaluation of imunohistochemical expression of Ki-67 in oral lichen planus, oral leukoplakia and normal mucosa cases. J Int Oral Health 2015; 7: 82-87
• 17 Dissanayake U, Johnson NW, Warnakulasuriya KA. Comparison of cell proliferation in the centre and advancing fronts of oral squamous cell carcinomas using Ki-67 index. Cell Prolif 2003; 36 (05) 255-264
• 18 Vieira FL, Vieira BJ, Guimaraes MA, Aarestrup FM. Cellular profile of the peritumoral inflammatory infiltrate in squamous cells carcinoma of oral mucosa: correlation with the expression of Ki67 and histologic grading. BMC Oral Health 2008; 8: 25
• 19 Piffkó J, Bánkfalvi A, Ofner D. et al. In situ assessment of cell proliferation at the invasive front of oral squamous cell carcinomas. Virchows Arch 1996; 429 (4-5) 229-234
• 20 Klieb HB, Raphael SJ. Comparative study of the expression of p53, Ki67, E-cadherin and MMP-1 in verrucous hyperplasia and verrucous carcinoma of the oral cavity. Head Neck Pathol 2007; 1 (02) 118-122
• 21 Zargaran M, Eshghyar N, Baghaei F, Moghimbeigi A. Assessment of cellular proliferation in oral verrucous carcinoma and well-differentiated oral squamous cell carcinoma using Ki67: a non-reliable factor for differential diagnosis?. Asian Pac J Cancer Prev 2012; 13 (11) 5811-5815
• 22 Saito T, Nakajima T, Mogi K. Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas. J Oral Pathol Med 1999; 28 (05) 226-232
• 23 Adegboyega PA, Boromound N, Freeman DH. Diagnostic utility of cell cycle and apoptosis regulatory proteins in verrucous squamous carcinoma. Appl Immunohistochem Mol Morphol 2005; 13 (02) 171-177